BINSA legislation to limit biotech deals in China unveiled in Senate
Contentious legislation that would clamp down on biotech and pharma deals in China has been introduced in the Senate, taking the baton from lawmakers in the House who first wrote it. Sens. Elissa Slotkin (D-MI) ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

